Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CLNN

CLNN News

Newswire

16:03

Clene shares surge 12.19% after-hours after JonesTrading and Benchmark reiterate Buy ratings with $30–$31 price targets following positive CNM-Au8 biomarker data analysis.

07:17

Clene shares jump 12.33% premarket after announcing significant ALS biomarker results supporting accelerated approval for CNM-Au8.

03:24

Clene (CLNN) Receives Buy Recommendation and Sees 235.17% Upside Potential

18:47

Clene shares surge 10.11% after hours as ALS biomarker results support accelerated approval pathway.

09:14

Clene shares surge 38.72% premarket after announcing statistically significant ALS biomarker results supporting accelerated FDA approval for CNM-Au8.

View More

About CLNN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More